Neil Desai
CIK 1878692 · EXECUTIVE CHAIRMAN · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
34
Lifetime Open-Market Net
-$3.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Director | — | $4.47 | — | $0 | 2 | 2026-06-15 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | EXECUTIVE CHAIRMAN | 639,698 | $2.05 | $1.31M | -$3.01M | 26 | 2024-09-05 |
Recent Filings · Page 3 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-01 | WHWK | Notice (144) | −126,000 | -$787.7K | EDGAR |
| 2023-08-03 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −42,000 | -$218.8K | EDGAR |
| 2023-07-06 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −42,000 | -$271.6K | EDGAR |
| 2023-07-03 | WHWK | Notice (144) | −84,000 | -$574.6K | EDGAR |
| 2023-06-06 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −7,260 | -$59.5K | EDGAR |
| 2023-06-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −34,740 | -$279.3K | EDGAR |
| 2023-05-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −2,305 | -$17.4K | EDGAR |
| 2023-05-03 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −39,695 | -$306.2K | EDGAR |
| 2023-04-06 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −12,212 | -$86.6K | EDGAR |
| 2023-04-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −29,788 | -$218.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.